Channels
All News
In Focus
Special
AI
Bioregnum
Biotech Voices
Cell/Gene Tx
China
Coronavirus
Deals
Diagnostics
Discovery
FDA+
Financing
Health Tech
Law
Letters to the Editor
Manufacturing
Marketing
Nikkei Biotechnology
Opinion
Outsourcing
Peer Review
People
Pharma
R&D
Startups
Weekly
Webinars
Biopharma Jobs
More
Work at Endpoints
Letter to Editors
Editorial Standards
IPO Tracker
Webinars
Events
Sponsored Posts
Advertise
Privacy Policy
Endpoints Merch
About Us
Help
SIGN UP
LOG IN
about the author
ENDPOINTS
editor@endpointsnews.com
author articles
Rein Therapeutics study on clinical hold; Beam updates sickle cell therapy data
Yesterday
News Briefing
ADC Therapeutics reveals layoffs, $100M PIPE; Third Harmonic seeks buyer for asset
2 days ago
News Briefing
Lilly pledges more than $650M to muscle health biotech; Cogent gets $50M
3 days ago
News Briefing
Insmed’s stock rallies on PAH data; Unicycive aims to resolve CDMO issues
4 days ago
News Briefing
Avidity to seek accelerated approval for FSHD drug; Axsome to run another trial
5 days ago
News Briefing
Kelun's $250M PIPE; Valneva moves chikungunya vaccine to Phase 3 for kids
Last week
News Briefing
Biopharma leaders carving a path for the industry’s LGBTQ+ community
Last week
People
Special
Cullinan's deal for T cell engager from China; Kardigan buys late-stage heart drug
Last week
News Briefing
Vigil drug fails a Phase 2; Merus aims to raise $300M
Last week
News Briefing
Sanofi pays out two STAT6 milestones; Theravance sells more Trelegy royalties
Last week
News Briefing
Roche’s 96-week data for multiple sclerosis drug; ZymeWorks claims $20M milestone
3 weeks ago
News Briefing
Taysha’s pivotal trial plans; Keros to stop work on PAH drug, lay off 45% of staff
3 weeks ago
News Briefing
Veru’s obesity drug roughly as safe as Wegovy; Keros’ board fight
3 weeks ago
News Briefing
ITM reveals up to $262M debt financing; Caris Life Sciences to go public
3 weeks ago
News Briefing
GLP-1s may cut cancer risk; Gyre’s stock falls after hep B data and offering
4 weeks ago
News Briefing
Moderna pulls application for Covid-flu shot; Another IPO in Hong Kong
4 weeks ago
News Briefing
SV Health’s $269M dementia fund; Schrödinger lays off 7% of staff
4 weeks ago
News Briefing
Ionis details late-stage data for heart drug; Armata’s promising staph infection therapy
4 weeks ago
News Briefing
FDA lifts hold on Scynexis trial; Incyte’s Zynyz notches another FDA approval
5 weeks ago
News Briefing
Enliven stops work on solid tumor drug; Pulmatrix to divest assets
5 weeks ago
News Briefing
SK, Carlyle bolster bluebird bio bid; Therini Bio raises $39M
Last month
News Briefing
Axsome's $570M loan with Blackstone; Altimmune makes its own credit deal
Last month
News Briefing
FDA clears in vivo blood stem cell editing trial; Abeona's $155M PRV sale
Last month
News Briefing
AstraZeneca reports Phase 3 win for Imfinzi; Roche to build new manufacturing site in China
Last month
News Briefing
1
2
3
4
Next page
Last page